| scholarly article | Q13442814 |
| P50 | author | Lori L. Altshuler | Q22003115 |
| Heinz Grunze | Q38642623 | ||
| Susan L McElroy | Q56816544 | ||
| Robert M. Post | Q87613308 | ||
| Mark A Frye | Q90298035 | ||
| Trisha Suppes | Q97540231 | ||
| Gabriele S. Leverich | Q111732463 | ||
| Paul E. Keck | Q111738411 | ||
| Jorge Walden | Q114420730 | ||
| Shoshanna Nakelsky | Q114430378 | ||
| P2093 | author name string | Jim Mintz | |
| Sun Hwang | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| modafinil | Q410441 | ||
| bipolar depression | Q56014658 | ||
| P304 | page(s) | 1242-1249 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression | |
| P478 | volume | 164 |
| Q91599142 | A Review of Psychostimulants for Adults With Depression |
| Q24613657 | A critical appraisal of treatments for bipolar disorder |
| Q47759280 | A re-examination of antidepressant treatment-emergent mania in bipolar disorders: evidence of gender differences |
| Q38163048 | A review of FDA-approved treatment options in bipolar depression |
| Q38090854 | A systematic review of the evidence for the treatment of acute depression in bipolar I disorder |
| Q97528159 | Adjunctive treatment with psychostimulants and stimulant-like drugs for resistant bipolar depression: a systematic review and meta-analysis |
| Q37316115 | Adjunctive use of modafinil in bipolar patients: just another stimulant or not? |
| Q60646345 | Akut- und Langzeittherapie der bipolaren Depressionen |
| Q37800587 | An Approach to Symptoms at the Interface of Medicine and Psychiatry: Pain, Insomnia, Weight Loss and Anorexia, Fatigue and Forgetfulness, and Sexual Dysfunction |
| Q28291968 | Approved and investigational uses of modafinil : an evidence-based review |
| Q34654574 | Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression |
| Q37952587 | Bipolar depression: an evidence-based approach |
| Q35236988 | Bipolar depression: trial-based insights to guide patient care. |
| Q28751133 | Bipolar disorder: candidate drug targets |
| Q52620604 | Caffeine and Modafinil Ameliorate the Neuroinflammation and Anxious Behavior in Rats during Sleep Deprivation by Inhibiting the Microglia Activation. |
| Q52656684 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. |
| Q36048483 | Characterization and factors associated with sleep quality in adolescents with bipolar I disorder. |
| Q38967863 | Cognitive dysfunction in major depression and bipolar disorder: Assessment and treatment options |
| Q28686902 | Current and emerging therapies for the management of bipolar disorders |
| Q38297855 | Current landscape, unmet needs, and future directions for treatment of bipolar depression |
| Q48186513 | Daytime sleepiness, sleep disturbance and functioning impairment in bipolar disorder |
| Q40047360 | Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability. |
| Q39159752 | Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis. |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q51850966 | Emerging drugs for bipolar disorder. |
| Q38063345 | Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review |
| Q26782989 | Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder |
| Q38226620 | Hyperactivity and sensation seeking as autoregulatory attempts to stabilize brain arousal in ADHD and mania? |
| Q35920392 | Hypersomnia in Mood Disorders: a Rapidly Changing Landscape |
| Q34042760 | Hypersomnia subtypes, sleep and relapse in bipolar disorder |
| Q39153990 | Hypersomnolence, Hypersomnia, and Mood Disorders. |
| Q34976344 | Insomnia in patients with depression: some pathophysiological and treatment considerations |
| Q58443915 | Ist manisches Verhalten ein autoregulatorischer Versuch zur Vigilanzstabilisierung? |
| Q92913293 | L-menthol exhibits antidepressive-like effects mediated by the modification of 5-HTergic, GABAergic and DAergic systems |
| Q35365539 | Management of bipolar depression |
| Q38297863 | Managing the side effects associated with commonly used treatments for bipolar depression |
| Q58695491 | Modafinil Induced Psychosis in a Patient with Bipolar 1 Depression |
| Q24235809 | Modafinil for schizophrenia |
| Q33940587 | Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study |
| Q91646389 | Neural predictors of treatment response to brain stimulation and psychological therapy in depression: a double-blind randomized controlled trial |
| Q38038979 | Neuroenhancement strategies for psychiatric disorders: rationale, status quo and perspectives. |
| Q37923845 | New drugs for bipolar disorder |
| Q38035727 | Obesity in bipolar disorder: an overview |
| Q29395337 | Options for Pharmacological Treatment of Refractory Bipolar Depression |
| Q38083305 | Overview of antidepressant treatment of bipolar depression |
| Q87505611 | Perils of Pragmatic Psychiatry: How We Can Do Better |
| Q41808917 | Pharmaceutical treatment of acute bipolar depression |
| Q38026866 | Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression |
| Q26783002 | Pharmacological Approaches for Treatment-resistant Bipolar Disorder |
| Q34349641 | Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis |
| Q37934626 | Pharmacological treatment of bipolar depression: qualitative systematic review of double-blind randomized clinical trials |
| Q35954969 | Pharmacotherapy for the treatment of acute bipolar II depression: current evidence |
| Q28744502 | Promising avenues of therapeutics for bipolar illness |
| Q89665753 | Psychopharmacology and Experimental Therapeutics for Bipolar Depression |
| Q38072063 | Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials |
| Q36017024 | Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatments |
| Q37960184 | Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling |
| Q92001769 | Recent advances in the biological treatment of mood disorders |
| Q57244624 | Recent progress in the pharmacotherapy of bipolar disorder |
| Q37954423 | Refractoriness in bipolar disorder: definitions and evidence-based treatment |
| Q26744364 | Review of Cohort Studies for Mood Disorders |
| Q26824365 | Review of evidence for use of antidepressants in bipolar depression |
| Q26853509 | Review of pharmacological treatment in mood disorders and future directions for drug development. |
| Q42717318 | Severe mania complicating treatment of narcolepsy with cataplexy. |
| Q60619766 | Social Cognition |
| Q50445984 | Something borrowed, something blue: why is bipolar disorder an orphan? |
| Q58443746 | Stimulants in bipolar disorder: beyond common beliefs |
| Q36562256 | Successful use of modafinil in treatment-resistant bipolar depression in an elderly woman |
| Q28066714 | The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm |
| Q34616633 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression |
| Q37881968 | Therapeutic options in treatment-resistant depression |
| Q38764892 | Treating bipolar depression - antidepressants and alternatives: a critical review of the literature |
| Q90700046 | Treatment of acute bipolar depression |
| Q57730484 | Treatment of bipolar depression |
| Q39112970 | Use of Stimulants in Bipolar Disorder. |
| Q38020283 | Use of adjunctive stimulants in adult bipolar depression |
| Q52881994 | [Pharmaceutical treatment of bipolar depression. Evidence from clinical guidelines and treatment recommendations]. |
Search more.